Find a Commonwealth Resource
Clorazepate dipotassium
HealthData.Gov
Updated Jun 12, 2026
About this dataset
Clorazepate Dipotassium is a prescription benzodiazepine medication available as oral tablets in strengths of 3.75 mg, 7.5 mg, and 15 mg. It is used to treat anxiety disorders and certain seizure types. Manufactured by ANI Pharmaceuticals, Inc., it is classified as a Schedule CIV controlled substance. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Clorazepate dipotassium
Access the FDA dataset for Clorazepate dipotassium — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025